| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J3490 |
Unclassified drugs |
88,118 |
24,445 |
$18.29M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
107,765 |
41,506 |
$1.62M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,994 |
8,268 |
$803K |
| 80053 |
Comprehensive metabolic panel |
4,769 |
4,466 |
$719K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
36,943 |
3,239 |
$451K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16,330 |
2,802 |
$355K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,944 |
6,204 |
$337K |
| A9270 |
Non-covered item or service |
24,644 |
2,310 |
$300K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
969 |
911 |
$254K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
208 |
187 |
$230K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
572 |
560 |
$145K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,949 |
2,752 |
$118K |
| 76770 |
|
692 |
658 |
$65K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
112 |
101 |
$52K |
| G0008 |
Administration of influenza virus vaccine |
4,923 |
762 |
$51K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
141 |
113 |
$45K |
| J2785 |
Injection, regadenoson, 0.1 mg |
716 |
216 |
$40K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,659 |
4,619 |
$39K |
| 93296 |
|
2,291 |
2,238 |
$31K |
| 74018 |
|
364 |
348 |
$29K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,397 |
1,317 |
$24K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
759 |
281 |
$23K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
772 |
284 |
$22K |
| A0434 |
Specialty care transport (sct) |
82 |
52 |
$21K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
332 |
126 |
$21K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
325 |
177 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,691 |
6,223 |
$19K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,081 |
1,348 |
$19K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,017 |
220 |
$19K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
385 |
162 |
$18K |
| Q3014 |
Telehealth originating site facility fee |
2,301 |
1,432 |
$17K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,806 |
3,304 |
$17K |
| G0378 |
Hospital observation service, per hour |
1,293 |
38 |
$12K |
| 11721 |
|
891 |
424 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
210 |
203 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,322 |
3,843 |
$10K |
| G0249 |
Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests |
329 |
296 |
$10K |
| 93325 |
|
1,391 |
1,287 |
$9K |
| 42830 |
|
23 |
22 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
5,037 |
4,130 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,081 |
142 |
$8K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
254 |
101 |
$6K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
353 |
120 |
$6K |
| 90837 |
Psychotherapy, 53 minutes with patient |
996 |
591 |
$5K |
| 54161 |
|
15 |
13 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
63 |
56 |
$5K |
| 97161 |
|
610 |
112 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,054 |
665 |
$5K |
| 87631 |
|
12 |
12 |
$4K |
| 93971 |
|
331 |
42 |
$4K |
| 0124A |
|
558 |
110 |
$3K |
| 81001 |
|
167 |
161 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
15 |
$3K |
| 93226 |
|
108 |
93 |
$3K |
| 97162 |
|
177 |
38 |
$3K |
| 64642 |
|
17 |
12 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,795 |
947 |
$3K |
| 0054A |
|
265 |
66 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
191 |
166 |
$2K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
102 |
40 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
90 |
12 |
$2K |
| 90480 |
|
336 |
68 |
$1K |
| 93970 |
|
60 |
12 |
$1K |
| 92134 |
|
26 |
12 |
$1K |
| G0009 |
Administration of pneumococcal vaccine |
319 |
59 |
$1K |
| 99222 |
Initial hospital care, per day, moderate complexity |
14 |
12 |
$1K |
| 36416 |
|
90 |
19 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
203 |
126 |
$1K |
| 97166 |
|
12 |
12 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
503 |
257 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
14 |
13 |
$970.31 |
| 99453 |
|
34 |
24 |
$919.18 |
| 93225 |
|
50 |
13 |
$915.12 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
58 |
47 |
$887.57 |
| 0004A |
|
263 |
59 |
$840.83 |
| 36415 |
Collection of venous blood by venipuncture |
95 |
92 |
$825.31 |
| 90834 |
Psychotherapy, 45 minutes with patient |
170 |
114 |
$787.41 |
| 0001A |
|
40 |
39 |
$737.23 |
| 84443 |
Thyroid stimulating hormone (TSH) |
44 |
41 |
$718.73 |
| 93320 |
|
96 |
89 |
$714.36 |
| 80061 |
Lipid panel |
50 |
48 |
$664.74 |
| J7999 |
Compounded drug, not otherwise classified |
255 |
166 |
$651.13 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
97 |
91 |
$630.47 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
55 |
27 |
$620.64 |
| C1769 |
Guide wire |
26 |
24 |
$592.52 |
| 99454 |
|
44 |
38 |
$581.95 |
| 0002A |
|
22 |
22 |
$551.22 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
17 |
15 |
$528.30 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
64 |
27 |
$382.51 |
| 84439 |
|
37 |
36 |
$346.68 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
29 |
12 |
$187.11 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
16 |
12 |
$184.57 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
33 |
25 |
$135.12 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
209 |
62 |
$103.16 |
| 85610 |
|
23 |
12 |
$57.90 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,569 |
1,003 |
$18.69 |
| 90686 |
|
433 |
413 |
$12.67 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
17 |
12 |
$12.67 |
| 83605 |
|
16 |
14 |
$11.57 |
| 90662 |
|
299 |
287 |
$10.12 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
249 |
211 |
$0.00 |
| 83735 |
|
72 |
71 |
$0.00 |
| 90656 |
|
44 |
44 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
71 |
53 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
15 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
12 |
12 |
$0.00 |
| 84484 |
|
18 |
16 |
$0.00 |
| 83690 |
|
20 |
15 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,781 |
681 |
$0.00 |
| 90671 |
|
79 |
77 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
169 |
136 |
$0.00 |
| 91320 |
|
130 |
129 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
42 |
13 |
$0.00 |
| 91300 |
|
20 |
18 |
$0.00 |
| 99152 |
|
14 |
12 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
14 |
12 |
$0.00 |
| 95874 |
|
17 |
12 |
$0.00 |